Xilio Therapeutics, Inc. (XLO)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
8. 88
-0.15
-1.6611%
$
59.37M Market Cap
- P/E Ratio
- Div Yield
55,700 Volume
-1.47 Eps
$ 9.03
Previous Close Want to track XLO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xilio Therapeutics, Inc. (XLO) Statistics
Valuation metrics
Market Cap 59.37M
Enterprise value -85.31M
Trailing P/E (ttm) -1.61
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) 1.09
Price/Book (mrq) 20.01
Enterprise Value/Revenue -1.6
Enterprise Value/EBITDA 2.85
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 56.07K
Average volume (90 days) 58.86K
Price summary
52-Week low 6.47
52-Week high 12.74
Beta -
50-Day moving average 8.57
200-Day moving average 8.26
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:14
Last split Date 16 Mar 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.59%
Operating margin -0.79%
Operational effectiveness
Return on assets -0.19%
Return on equity -1.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.33
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.19
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.92
Total debt (mrq) -
Total Debt/Equity (mrq) 0.09
Current ratio (mrq) 3.59%
Book value per share (mrq) 0.44
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
